Cenzone Tech v. Wu CA4/1

CourtCalifornia Court of Appeal
DecidedMay 23, 2023
DocketD079891
StatusUnpublished

This text of Cenzone Tech v. Wu CA4/1 (Cenzone Tech v. Wu CA4/1) is published on Counsel Stack Legal Research, covering California Court of Appeal primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Cenzone Tech v. Wu CA4/1, (Cal. Ct. App. 2023).

Opinion

Filed 5/23/23 Cenzone Tech v. Wu CA4/1 NOT TO BE PUBLISHED IN OFFICIAL REPORTS California Rules of Court, rule 8.1115(a), prohibits courts and parties from citing or relying on opinions not certified for publication or ordered published, except as specified by rule 8.1115(b). This opinion has not been certified for publication or ordered published for purposes of rule 8.1115.

COURT OF APPEAL, FOURTH APPELLATE DISTRICT

DIVISION ONE

STATE OF CALIFORNIA

CENZONE TECH., INC., D079891

Plaintiff, Cross-defendant and Appellant; (Super. Ct. No. 37-2019- JUNG FU WU, 00029703-CU-BC-NC)

Cross-defendant and Appellant,

v.

MARK KANE-BERMAN et al.,

Defendants, Cross-complainants and Respondents.

APPEAL from a judgment of the Superior Court of San Diego County, Cynthia A. Freeland, Judge. Affirmed. Niddrie Addams Fuller Singh and Rupa G. Singh for Plaintiff, Cross- defendant, and Appellant Cenzone Tech., Inc., and Cross-defendant and Appellant Jung Fu Wu. Duckor Metzger & Wynne, Tony R. Skogen, Jr., and Cathleen G. Fitch for Defendants, Cross-complainants and Respondents. I INTRODUCTION Plaintiff and cross-defendant Cenzone Tech, Inc. (Cenzone) appeals an order granting a motion for entry of judgment filed by defendant and cross- complainant Mark Kane-Berman and cross-complainant Microbasics, LLC (Microbasics) under Code of Civil Procedure section 664.6. The trial court entered judgment after finding that the parties executed a valid settlement agreement resolving all causes of action between them, known and unknown. According to Cenzone, the settlement agreement was unenforceable because Cenzone never intended to settle causes of action that were known to the parties, but unasserted in their pleadings. Cenzone also argues the court erred by denying its motion for leave to amend its complaint to assert several new causes of action against Kane-Berman and Microbasics. We conclude the trial court properly granted the motion for entry of judgment pursuant to the parties’ settlement agreement, which clearly and unambiguously released all claims between the parties, known and unknown. Further, we conclude the court did not prejudicially err in denying Cenzone’s motion for leave to amend its complaint. Therefore, we affirm the order denying Cenzone’s motion for leave to amend its complaint and the order entering judgment pursuant to the parties’ settlement agreement. II BACKGROUND 1. The Pleadings Dr. Jung Fu Wu is the president and founder of Cenzone, a manufacturer of livestock feed supplements. Mark Kane-Berman owns and operates Microbasics, a company in the same line of business.

2 On June 7, 2019, Cenzone filed a complaint asserting four causes of action against Kane-Berman and Kane-Berman dba Microbasics. In its first cause of action, Cenzone alleged it loaned nearly $488,000 to Kane-Berman to buy real property in Jerome, Idaho. Cenzone claimed Kane-Berman breached a promissory note memorializing the loan by failing to repay about $255,000 in principal and not making required interest payments. In its second and third causes of action, Cenzone averred that Kane-Berman agreed to buy livestock feed products from Cenzone, but failed to pay for the products in full. The fourth cause of action asserted that Cenzone provided livestock feed products to Kane-Berman on an open book account and he owed a balance on the account. Cenzone prayed for damages of about $446,000. Kane-Berman answered by generally denying Cenzone’s allegations. On February 14, 2020, Kane-Berman and Microbasics filed a cross- complaint against Cenzone, Wu, and other cross-defendants. They asserted crossclaims for defamation, misappropriation of trade secrets, and goods and services rendered. Additionally, they requested declarations that they: (1) never agreed to the promissory note memorializing the loan for the acquisition of the Idaho property; (2) owed Cenzone no money under the promissory note; and (3) had sole ownership of the Idaho property. 2. Cenzone’s Motion for Leave to Amend its Complaint On October 21, 2020, Cenzone filed a motion for leave to amend its complaint by adding seven new causes of action against Kane-Berman and Microbasics. Cenzone requested leave to assert declaratory relief and fraudulent concealment causes of action based on allegations that Kane- Berman and Wu agreed to buy the Idaho property as equal partners, but Kane-Berman forged Wu’s signature on documentation relating to the sale and, through this deceit, acquired sole title to the property. Cenzone also

3 sought to pursue a cause of action for misappropriation of trade secrets. Finally, Cenzone sought leave to assert civil theft, unfair business practices, trade libel, and intentional interference with prospective economic advantage causes of action based on allegations that Kane-Berman disparaged Cenzone and its feed supplements to customers. The proposed amended complaint prayed for damages exceeding $10,000,000. On January 7, 2021, Kane-Berman opposed Cenzone’s motion for leave to amend its complaint. He argued Cenzone should not be allowed to assert the declaratory relief and fraudulent concealment causes of action because the allegations underlying those causes of action—i.e., the allegations that Kane-Berman forged Wu’s signature to take sole title to the Idaho property— were fatally inconsistent with the original complaint’s allegations that Wu loaned him money to buy the property. On January 8, 2021, Cenzone filed a so-called amendment to its motion for leave to amend its complaint. Through the amendment, Cenzone sought to add two additional causes of action (for a total of nine new ones): (1) a cause of action that Kane-Berman conspired to misappropriate Cenzone’s trade secrets; and (2) a cause of action for violations of 15 U.S.C. § 1125, based on Kane-Berman’s allegedly false statements to Cenzone’s customers. On February 4, 2021, Kane-Berman opposed Cenzone’s amended motion for leave to amend its complaint. He reiterated his contentions from the previously filed opposition and further argued that the proposed amendment would severely prejudice him. He argued he would suffer prejudice because: (1) the new causes of action would substantially enlarge the scope of the case; (2) the amendment would delay trial, set for July 16, 2021, because it would unsettle the pleadings and necessitate new discovery; and (3) Cenzone unduly delayed seeking amendment. On the issue of undue

4 delay, Kane-Berman asserted Cenzone inexplicably waited fourteen months to pursue its proposed amendment, even though it was aware of the allegations underlying its new causes of action at the outset of the case. On February 10, 2021, Cenzone filed a reply in support of its amended motion for leave to amend its complaint. It asserted there was no inconsistency between its claim that it loaned money to Kane-Berman to finance the acquisition of the Idaho property, on the one hand, and its claim that Wu and Kane-Berman agreed to take title to the property as equal partners, on the other hand. Further, it argued its failure to seek amendment earlier was “not due to a lack of diligence by Dr. Wu or Cenzone,” but rather “due to concealment and malfeasance” by Kane-Berman. On February 19, 2021, the court denied Cenzone’s amended motion for leave to amend its complaint. The court found Cenzone was “partially dilatory in seeking leave to amend” because it “ha[d] at all times known, or should have known, of potential title issues” relating to the Idaho property.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Natkin v. California Unemployment Insurance Appeals Board
219 Cal. App. 4th 997 (California Court of Appeal, 2013)
Levy v. Skywalker Sound
134 Cal. Rptr. 2d 138 (California Court of Appeal, 2003)
Stewart v. Preston Pipeline Inc.
36 Cal. Rptr. 3d 901 (California Court of Appeal, 2005)
Hines v. Lukes
167 Cal. App. 4th 1174 (California Court of Appeal, 2008)
Luri v. Greenwald
132 Cal. Rptr. 2d 680 (California Court of Appeal, 2003)
Critzer v. Enos
187 Cal. App. 4th 1242 (California Court of Appeal, 2010)
Cassim v. Allstate Insurance
94 P.3d 513 (California Supreme Court, 2004)
Donovan v. RRL Corp.
27 P.3d 702 (California Supreme Court, 2001)
Leeman v. Adams Extract & Spice CA1/4
236 Cal. App. 4th 1367 (California Court of Appeal, 2015)
F.People v. Monier
405 P.3d 1076 (California Supreme Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Cenzone Tech v. Wu CA4/1, Counsel Stack Legal Research, https://law.counselstack.com/opinion/cenzone-tech-v-wu-ca41-calctapp-2023.